Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

10. November 2016 16:15 ET | Quelle: Cellectar Biosciences, Inc.

Cellectar Biosciences Announces Recent Key Accomplishments and Third Quarter 2016 Financial Results

MADISON, Wisc., Nov. 10, 2016 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB) (the “company”), an oncology-focused, clinical stage biotechnology company, today announces key...
07. November 2016 08:30 ET | Quelle: Cellectar Biosciences, Inc.

Cellectar Biosciences to Host Conference Call on November 11 to Report Third Quarter 2016 Financial Results and Corporate Performance

MADISON, Wis., Nov. 07, 2016 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), (the “company”), an oncology-focused, clinical stage biotechnology company, today announces that...
31. Oktober 2016 09:45 ET | Quelle: Cellectar Biosciences, Inc.

Cellectar Biosciences Announces Design for NCI-Supported Phase II Study of CLR 131 in Multiple Myeloma and Other Hematologic Malignancies

MADISON, Wis., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB) (the “company”), an oncology-focused, clinical stage biotechnology company, today announces the study...
24. Oktober 2016 08:30 ET | Quelle: Cellectar Biosciences, Inc.

Cellectar Biosciences Announces Data on CLR 131 Accepted For Poster Presentation at the 58th Annual American Society of Hematology Meeting & Exposition

MADISON, Wis., Oct. 24, 2016 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB) (the “company”), an oncology-focused, clinical stage biotechnology company, today announces that it will be...
13. Oktober 2016 08:30 ET | Quelle: Cellectar Biosciences, Inc.

Cellectar Biosciences To Present at BIO Investor Forum

MADISON, Wis., Oct. 13, 2016 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB) (the “company”), an oncology-focused, clinical stage biotechnology company, today announces that Jarrod...
11. Oktober 2016 08:30 ET | Quelle: Cellectar Biosciences, Inc.

Cellectar Biosciences To Present at SeeThru Equity and Dawson James Investor Conferences

MADISON, Wis., Oct. 11, 2016 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB) (the “company”), an oncology-focused, clinical stage biotechnology company, today announces that Jim...
06. Oktober 2016 08:30 ET | Quelle: Cellectar Biosciences, Inc.

Cellectar Biosciences Announces Enrollment of First Patient into Third Cohort of Its Phase I Clinical Study of CLR 131 in Multiple Myeloma

MADISON, Wis., Oct. 06, 2016 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB) (the “company”), an oncology-focused clinical stage biotechnology company, today announces the...
04. Oktober 2016 08:30 ET | Quelle: Cellectar Biosciences, Inc.

Cellectar Biosciences Announces USPTO Issues Formal Patent Allowance for CLR 1603

MADISON, Wis., Oct. 04, 2016 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB) (the “company”), an oncology-focused clinical stage biotechnology company, today announces that the...
29. September 2016 08:30 ET | Quelle: Cellectar Biosciences, Inc.

Cellectar Biosciences Announces New Positive Data from Phase I Clinical Study of CLR 131 in Multiple Myeloma

MADISON, Wis., Sept. 29, 2016 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB) (the “company”), an oncology-focused biotechnology company, today announces positive data from the...
21. September 2016 08:30 ET | Quelle: Cellectar Biosciences, Inc.

Cellectar Biosciences To Present at OktoberINVESTfest

MADISON, Wis., Sept. 21, 2016 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB) (the “company”), an oncology-focused biotechnology company, today announces that Jim Caruso, president...

Vorherige Seite